Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-23Clinical Trial Update: AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer [Phase 1, Phase 2]
A clinical trial evaluating the combination of bevacizumab and bemarituzumab for gynecologic cancers (endometrial, ovarian, and cervical) ha…
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer [NA]
Withdrawn clinical trial evaluating a virtual mental health intervention for fear of progression in women with high-risk or stage III-IV gyn…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer [NA]
A clinical trial evaluating quality of life during radiotherapy for recurrent head and neck cancer has been withdrawn; the study also listed…
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]
A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-10-14Clinical Trial Update: 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy [Phase 2]
A Phase 2 trial evaluating 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a biomarker for response to progesterone therapy in endometrial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics reports termination of a Phase I/II autologous TCR-T cell trial across several solid tumors. The study focused on HLA t…
-
CLINICAL_TRIALS withdrawal · 2025-07-01Clinical Trial Update: A Study to Investigate LYL797 in Adults With Solid Tumors [Phase 1]
Lyell Immunopharma's Phase 1 study of LYL797 in adults with solid tumors has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer [Phase 1, Phase 2]
The LiDer protocol study of lurbinectedin and dostarlimab in cancer patients has been withdrawn, with endometrial cancer as the specified co…
-
CLINICAL_TRIALS withdrawal · 2025-03-28Clinical Trial Update: Endometrial Cancer Recurrence in Patients Taking Metformin
The clinical trial investigating metformin in patients with recurrent endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors [Phase 1]
A Phase 1 trial evaluating ASP1893 in adults with CLDN6-positive solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-19Clinical Trial Update: Niraparib in High-grade Endometrial Cancer Trial [EARLY_Phase 1]
A Phase 1 Niraparib trial for high-grade endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Laser Treatment of Genito-urinary Syndrome in Women [NA]
A clinical trial investigating laser treatment for genitourinary syndrome of menopause in women has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-02Clinical Trial Update: AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer [Phase 1]
A Phase 1 trial evaluating batiraxcept (AVB-500) in combination with paclitaxel for recurrent high-grade endometrial cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas [NA]
A clinical trial evaluating sentinel lymph node policy in intermediate-risk endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2024-08-14Clinical Trial Update: Biomarkers in Samples From Patients With Endometrial Cancer
This clinical trial update reports that the biomarker study in endometrial cancer samples sponsored by Gynecologic Oncology Group has been w…
-
CLINICAL_TRIALS withdrawal · 2024-04-30Clinical Trial Update: GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer [Phase 2]
A Phase 2 trial of GEN1046 in combination with anticancer agents for advanced endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-11-03Clinical Trial Update: Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer [Phase 3]
A Phase 3 trial comparing letrozole with lerociclib versus letrozole with placebo in advanced/metastatic or recurrent endometrial cancer was…
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]
The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors [Phase 1, Phase 2]
The trial evaluating 18F-Fluciclatide PET/CT imaging for anti-angiogenic therapy in solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids [NA]
The clinical trial aimed to identify biomarkers for ovarian and endometrial cancers in vaginal fluids, but the study has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-29Clinical Trial Update: Lenvatinib in Second Line Endometrial Carcinoma [Phase 2]
The Phase 2 clinical trial of lenvatinib for second-line endometrial cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-30Clinical Trial Update: Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating gum chewing to accelerate recovery of bowel function after abdominal surgery for endometrial and ovari…
-
CLINICAL_TRIALS withdrawal · 2016-08-30Clinical Trial Update: Endometrial Cancer Biomarker Changes Following Exposure to Metformin [Phase 2]
Phase 2 trial investigating biomarker changes in endometrial cancer after metformin exposure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-09Clinical Trial Update: Regional Anesthesia and Endometrial Cancer Recurrence [Phase 3]
A Phase 3 clinical trial investigating regional anesthesia and recurrence of endometrial cancer has been withdrawn.